# Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

> **NCT00502775** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 680 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** fluticasone furoate, fexofenadine

## Key facts

- **NCT ID:** NCT00502775
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 680 (ACTUAL)
- **Last updated:** 2016-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502775, "Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00502775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*